Skip to content

Survey of the Need for Information on Fertility and Menopause-Related Treatment Effects Among HSCT Patients

Survey of the Need for Information on Fertility and Menopause-Related Treatment Effects Among Young Women Who Underwent Hematopoietic Stem Cell Transplantation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00429455
Enrollment
196
Registered
2007-01-31
Start date
2007-03-31
Completion date
2009-08-31
Last updated
2012-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stem Cell Transplantation

Keywords

Fertility, Menopause, Hematopoietic Stem Cell Transplantation, Questionnaire, Survey

Brief summary

Primary Objective: \- To understand the importance of receiving information on fertility- and menopause-related treatment effects for female patients undergoing hematopoietic stem cell transplantation.

Detailed description

Researchers are currently conducting a survey on how important it is to women who are having a stem cell transplant to have information about the effects of the treatment on their fertility (their ability to have children) and on the risk of early menopause. Researchers know that some women who had transplants think that the information that they received may have been lacking or was not appropriate for their needs. Therefore, researchers would like to ask women who have had stem cell transplants at M. D. Anderson Cancer Center to report what kind of information they got and would like to have gotten before or during their treatment.

Interventions

BEHAVIORALSurvey

3-Part Questionnaire

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Female patients who had a hematopoietic stem cell transplantation between January 1987 and September 2004 at M. D. Anderson Cancer Center. * Age 16 to 50 years at the time of the transplant.

Exclusion criteria

* History of ovarian cancer. * History of hysterectomy/oophorectomy * Non-English speaking patients

Design outcomes

Primary

MeasureTime frame
Number of Survey Responders2 Years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026